Videos
video: May 3, 2026
Lenti with Friends
Episode 6: An Industry Stalwart
Dr. Adam Inche
Founder & CEO, Lentitek
Farzin Farzaneh, PhD
Co-Founder & CSO, ViroCell Biologics
A discussion about Lentitek and ViroCell’s joint project for achieving vectors with higher payloads and titre.
WEBINAR: September 3, 2025
Next-gen vectors:
advancing in vivo and ex vivo gene delivery through intelligent design
BioInsights
Speakers
Nagy Habib, MD, ChM, FRCS
CEO, Dawn Therapeutics
John Maher, MD
Chief Science Officer, Leucid Bio
Carlo Scala, PhD
Director of Process Development and Innovation, ViroCell Biologics
Moderator
Abigail Pinchbeck
Editor, BioInsights
PANEL: April 16, 2025
Advancing Gene Therapies for Rare Diseases: Implementing Novel Strategies for Not-For-Profit Innovation
Alliance for Regenerative Medicine, Rome
Moderator
John W. Hadden II
CEO, ViroCell Biologics
Panelists
Hilary Eaton, PhD
Chief Business Officer, Profluent.bio
Sadik Kassim, PhD
Chief Scientific Officer & Chief Technology Officer, Danaher Genomic Medicines
Maryam Mokhtarzadeh, MD
Senior Director, Regulatory Strategy, REGENXBIO
Hilary Schultz
CEO & Founder, Persephoni BioPartners